Rabeprazole Sodium
These highlights do not include all the information needed to use RABEPRAZOLE SODIUM DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for RABEPRAZOLE SODIUM DELAYED-RELEASE TABLETS. RABEPRAZOLE SODIUM delayed-release tablets, for oral use Initial U.S. Approval: 1999
12eaf996-db61-41d6-82e1-fa6196435603
HUMAN PRESCRIPTION DRUG LABEL
Jun 26, 2020
Asclemed USA, Inc.
DUNS: 059888437
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Rabeprazole Sodium
Product Details
FDA regulatory identification and product classification information